Manal Nicolas-Jilwan

Manal Nicolas-Jilwan

Auto-generated profile, based on publicly available information

Manal Nicolas-Jilwan

Division of Neuroradiology, Department of Radiology, King Faisal Specialist Hospital and Research Centre, Al Zahrawi Street, Riyadh, 11211, Saudi Arabia.

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2021 in Stroke
Verified
Journal Article
Closed access
PDF file
MNManal Nicolas-Jilwan
Manal Nicolas-Jilwan
MWMax Wintermark
Max Wintermark
Recent advancements in computed tomography technology, including improved brain coverage and automated processing of the perfusion data, have reinforced the use of perfusion computed tomography imaging in the routine evaluation of patients with acute ischemic stroke. The DAWN (Diffusion Weighted Imaging or Computerized Tomography Perfusion Assessment With Clinical Mismatch in the Triage of Wake Up and Late Presenting Strokes Undergoing Neurointervention) and DEFUSE 3 (Endovascular Therapy Following Imaging Evaluation for Ischemic Stroke 3) trials have established the benefit of endovascular thrombectomy in patients with acute ischemic stroke with anterior circulation large vessel occlusion up to 24 hours of last seen normal, using perfusion imaging-based patient selection. The compelling data has prompted stroke centers to increasingly introduce automated perfusion computed tomography imaging in the routine evaluation of patients with acute ischemic stroke. We present a comprehensive overview of the acquisition and interpretation of automated perfusion imaging in patients with acute ischemic stroke with a special emphasis on the interpretation pearls, pitfalls, and stroke mimicking conditions.

11 May 2018 in Pediatric Radiology
Verified
Journal Article
Closed access
PDF file
MNManal Nicolas-Jilwan
Manal Nicolas-Jilwan
MAMoeenaldeen AlSayed
Moeenaldeen AlSayed

7 January 2019 in The Neuroradiology Journal
Verified
Journal Article
Closed access
MNManal Nicolas-Jilwan
Manal Nicolas-Jilwan
Recessive congenital methemoglobinemia type II is a very rare autosomal recessive hematologic disorder due to NADH-cytochrome b5 reductase deficiency, usually caused by full-stop mutations or deletions. This disease classically presents with mild neonatal cyanosis, early onset severe progressive developmental delay, movement disorders, and progressive microcephaly. We report two siblings with recessive congenital methemoglobinemia type II whose evaluation revealed a novel p.Arg92Trp missense mutation of the CYB5R3 gene and a peculiar imaging finding of basal ganglia hypoplasia. Brain magnetic resonance imaging was performed at age 10 months in the older sibling and at age three months in the younger sibling. It revealed similar findings of bilateral small size of the lentiform and caudate nuclei and reduced frontotemporal brain volume. Our patient cases highlight that basal ganglia hypoplasia is an interesting clue to the very rare and frequently unsuspected diagnosis of recessive congenital methemoglobinemia type II, that may explain the associated movement disorders. The novel missense mutation is one of very few identified missense mutations known to cause severe type II recessive congenital methemoglobinemia.

1 October 2011 in Journal Of Neuroradiology
Verified
Journal Article
Closed access
MNM. Nicolasjilwan
M. Nicolasjilwan
HOH. Ozer
H. Ozer
MWMax Wintermark
Max Wintermark
JMJ. Matsumoto
J. Matsumoto

1 July 2020 in International Journal of Pediatric Otorhinolaryngology
Verified
Journal Article
Closed access
MNManal Nicolas-Jilwan
Manal Nicolas-Jilwan

21 April 2020 in Neuroradiology
Verified
Journal Article
Closed access
PDF file
MNManal Nicolas-Jilwan
Manal Nicolas-Jilwan
RMRita Medlej
Rita Medlej
RSRaashda A Sulaiman
Raashda A Sulaiman
MAMoeenaldeen AlSayed
Moeenaldeen AlSayed